These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18648368)

  • 1. Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells.
    O'Callaghan G; Kelly J; Shanahan F; Houston A
    Br J Cancer; 2008 Aug; 99(3):502-12. PubMed ID: 18648368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoic acid morpholine amide (RAMA) inhibits expression of Fas ligand through EP1 receptor in colon cancer cells.
    Chen SX; Du SY; Wang YT; Zhao HC; Zhang YL; Yao L
    Tumour Biol; 2016 Jan; 37(1):323-9. PubMed ID: 26211005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation and apoptosis in Clostridium difficile enteritis is mediated by PGE2 up-regulation of Fas ligand.
    Kim H; Rhee SH; Pothoulakis C; Lamont JT
    Gastroenterology; 2007 Sep; 133(3):875-86. PubMed ID: 17854595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells.
    Bai XM; Jiang H; Ding JX; Peng T; Ma J; Wang YH; Zhang L; Zhang H; Leng J
    Life Sci; 2010 Jan; 86(5-6):214-23. PubMed ID: 20035770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the EP1 receptor reduces Fas ligand expression and increases the antitumor immune response in an in vivo model of colon cancer.
    O'Callaghan G; Ryan A; Neary P; O'Mahony C; Shanahan F; Houston A
    Int J Cancer; 2013 Aug; 133(4):825-34. PubMed ID: 23390011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells.
    Cherukuri DP; Chen XB; Goulet AC; Young RN; Han Y; Heimark RL; Regan JW; Meuillet E; Nelson MA
    Exp Cell Res; 2007 Aug; 313(14):2969-79. PubMed ID: 17631291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas ligand promotes tumor immune evasion of colon cancer in vivo.
    Ryan AE; Shanahan F; O'Connell J; Houston AM
    Cell Cycle; 2006 Feb; 5(3):246-9. PubMed ID: 16418579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells.
    Han C; Michalopoulos GK; Wu T
    J Cell Physiol; 2006 Apr; 207(1):261-70. PubMed ID: 16331686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2 stimulates fibronectin expression through EP1 receptor, phospholipase C, protein kinase Calpha, and c-Src pathway in primary cultured rat osteoblasts.
    Tang CH; Yang RS; Fu WM
    J Biol Chem; 2005 Jun; 280(24):22907-16. PubMed ID: 15833739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of antitumor drugs on the expression of Fas system in SW480 colon cancer cells.
    Zhu Q; Liu JY; Yang CM; Xu HW; Zhang AZ; Cui Y; Wang HB; Qin CY; Li YQ
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1071-7. PubMed ID: 16957513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development.
    Shoji Y; Takahashi M; Kitamura T; Watanabe K; Kawamori T; Maruyama T; Sugimoto Y; Negishi M; Narumiya S; Sugimura T; Wakabayashi K
    Gut; 2004 Aug; 53(8):1151-8. PubMed ID: 15247185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E2/EP1 signaling pathway enhances intercellular adhesion molecule 1 (ICAM-1) expression and cell motility in oral cancer cells.
    Yang SF; Chen MK; Hsieh YS; Chung TT; Hsieh YH; Lin CW; Su JL; Tsai MH; Tang CH
    J Biol Chem; 2010 Sep; 285(39):29808-16. PubMed ID: 20647315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cytokines in promoting immune escape of FasL-expressing human colon cancer cells.
    Xu T; Sun BC; Li Q; Hao XS
    World J Gastroenterol; 2005 Jul; 11(25):3915-9. PubMed ID: 15991293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is FAS/Fas ligand system involved in equine corpus luteum functional regression?
    Galvao AM; Ramilo DW; Skarzynski DJ; Lukasik K; Tramontano A; Mollo A; Mateus LM; Ferreira-Dias GM
    Biol Reprod; 2010 Dec; 83(6):901-8. PubMed ID: 20720169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of FasL expression in tumor cells and preventing TNF-induced apoptosis was better for immune cells survival.
    Xu G; Zhang J
    J Cancer Res Clin Oncol; 2008 Oct; 134(10):1043-9. PubMed ID: 18461366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas.
    Shiraki K; Tsuji N; Shioda T; Isselbacher KJ; Takahashi H
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6420-5. PubMed ID: 9177233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indomethacin decreases EP2 prostanoid receptor expression in colon cancer cells.
    Fujino H; Chen XB; Regan JW; Murayama T
    Biochem Biophys Res Commun; 2007 Aug; 359(3):568-73. PubMed ID: 17555711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas and Fas ligand expression in tumor cells and in vascular smooth-muscle cells of colonic and renal carcinomas.
    Peduto Eberl L; Guillou L; Saraga E; Schröter M; French LE; Tschopp J; Juillerat-Jeanneret L
    Int J Cancer; 1999 May; 81(5):772-8. PubMed ID: 10328232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer.
    O'Connell J; Bennett MW; O'Sullivan GC; Roche D; Kelly J; Collins JK; Shanahan F
    J Pathol; 1998 Nov; 186(3):240-6. PubMed ID: 10211111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CC531s colon carcinoma cells induce apoptosis in rat hepatic endothelial cells by the Fas/FasL-mediated pathway.
    Vekemans K; Timmers M; Vermijlen D; De Zanger R; Wisse E; Braet F
    Liver Int; 2003 Aug; 23(4):283-93. PubMed ID: 12895269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.